Authors:
LISSONI P
TANCINI G
BARNI S
PAOLOROSSI F
ARDIZZOIA A
CONTI A
MAESTRONI G
Citation: P. Lissoni et al., TREATMENT OF CANCER CHEMOTHERAPY-INDUCED TOXICITY WITH THE PINEAL HORMONE MELATONIN, Supportive care in cancer, 5(2), 1997, pp. 126-129
Authors:
LISSONI P
CAZZANIGA M
TANCINI G
SCARDINO E
MUSCI R
BARNI S
MAFFEZZINI M
MERONI T
ROCCO F
CONTI A
MAESTRONI G
Citation: P. Lissoni et al., REVERSAL OF CLINICAL RESISTANCE TO LHRH ANALOG IN METASTATIC PROSTATE-CANCER BY THE PINEAL HORMONE MELATONIN - EFFICACY OF LHRH ANALOG PLUSMELATONIN IN PATIENTS PROGRESSING ON LHRH ANALOG ALONE, European urology, 31(2), 1997, pp. 178-181
Authors:
FILIPPINI G
TOGNI M
MAESTRONI G
EPPENBERGER HM
CAVALLI F
SOLDATI G
Citation: G. Filippini et al., P53 ACTIVATION MEDIATES CELL-DEATH OR DIFFERENTIATION IN PRE-B LEUKEMIA-CELL LINE, Experimental hematology, 24(9), 1996, pp. 473-473
Authors:
LISSONI P
MEREGALLI S
NOSETTO L
BARNI S
TANCINI G
FOSSATI V
MAESTRONI G
Citation: P. Lissoni et al., INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE, Oncology, 53(1), 1996, pp. 43-46
Authors:
LISSONI P
ARDIZZOIA A
BARNI S
BRIVIO F
TISI E
ROVELLI F
TANCINI G
MAESTRONI G
FUMAGALLI L
Citation: P. Lissoni et al., EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS, Oncology Reports, 2(6), 1995, pp. 1063-1068
Authors:
BRIVIO F
LISSONI P
FUMAGALLI L
BRIVIO O
LAVORATO F
RESCALDANI R
CONTI A
ROSELLI MG
MAESTRONI G
BARNI S
Citation: F. Brivio et al., PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA, Oncology Reports, 2(4), 1995, pp. 597-599
Authors:
LISSONI P
BARNI S
ARDIZZOIA A
TANCINI G
CONTI A
MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH THE PINEAL HORMONE MELATONIN VERSUS SUPPORTIVE CARE ALONE IN PATIENTS WITH BRAIN METASTASES DUE TO SOLID NEOPLASMS, Cancer, 73(3), 1994, pp. 699-701
Authors:
LISSONI P
BARNI S
TANCINI G
ARDIZZOIA A
RICCI G
ALDEGHI R
BRIVIO F
TISI E
ROVELLI F
RESCALDANI R
QUADRO G
MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA, British Journal of Cancer, 69(1), 1994, pp. 196-199